Neuro-Bio Logo - Kairos Ventures portfolio

Company Summary

Neuro-Bio is an early stage biopharmaceutical company focused on developing novel, effective therapeutics for neurodegenerative disorders including Alzheimer’s, Parkinson’s and Motor Neuron Diseases.

Year Founded:  2013

Key Executives:
Baroness Professor Susan Greenfield, CEO, Founder & Board Member

Location:  Oxford, United Kingdom

Website:  http://www.neuro-bio.com/

Company Status:  Private

Year Invested:  2016

Investment Status:  Current

Board Member:
Dave Fuente